Edmund K Waller Selected Research

Edmund K Waller Research Topics

Disease

45	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2002
42	Neoplasms (Cancer) 01/2022 - 04/2003
33	Leukemia 01/2022 - 04/2003
21	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 01/2002
19	Infections 10/2017 - 02/2002
16	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 01/2007
15	Lymphoma (Lymphomas) 01/2020 - 12/2004
13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 01/2007
13	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 11/2012
12	Bronchiolitis Obliterans Syndrome 10/2019 - 05/2007
12	Multiple Myeloma 01/2019 - 12/2005
9	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 10/2016
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 10/2006
7	Thrombocytopenia (Thrombopenia) 01/2019 - 09/2002
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 03/2015
5	Pain (Aches) 12/2020 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 05/2014
5	Breast Neoplasms (Breast Cancer) 01/2019 - 09/2002
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 04/2010
4	Pathologic Complete Response 01/2020 - 02/2012
4	Melanoma (Melanoma, Malignant) 01/2019 - 04/2003
4	Hodgkin Disease (Hodgkin's Disease) 01/2016 - 10/2006
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 09/2015
3	Inflammation (Inflammations) 11/2021 - 11/2017
3	Peripheral Arterial Disease 01/2020 - 07/2009
3	Ischemia 01/2020 - 10/2016
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2015 - 04/2013
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 01/2007
3	Neutropenia 04/2013 - 04/2009
3	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 09/2009
2	Myocardial Infarction 11/2021 - 01/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 01/2019
2	Disease Progression 10/2021 - 01/2019
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2020
2	Cytokine Release Syndrome 11/2020 - 01/2019
2	Human Influenza (Influenza) 10/2020 - 12/2002
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 10/2016

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 01/2021 - 12/2002
12	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019 - 12/2004
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 06/2007
10	Busulfan (Busulfex)FDA Link 01/2020 - 01/2002
9	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2018
9	tisagenlecleucelIBA 01/2022 - 12/2018
8	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 12/2002
7	Peptides (Polypeptides)IBA 01/2021 - 04/2004
7	Pharmaceutical PreparationsIBA 09/2020 - 02/2002
6	fludarabineIBA 01/2020 - 10/2003
6	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2020 - 10/2016
6	Calcineurin InhibitorsIBA 10/2019 - 10/2016
6	Etoposide (VP 16)FDA LinkGeneric 01/2016 - 10/2006
5	plerixafor FDA Link 01/2019 - 10/2011
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 01/2002
5	AntibodiesIBA 01/2019 - 12/2002
5	CytokinesIBA 12/2018 - 04/2003
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2018
4	EpitopesIBA 01/2021 - 01/2013
4	CXC ChemokinesIBA 08/2020 - 10/2017
4	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 10/2010
4	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 01/2002
4	(VIP-neurotensin) hybrid antagonistIBA 01/2017 - 01/2013
4	Bortezomib (Velcade)FDA Link 02/2015 - 12/2005
4	HLA Antigens (Human Leukocyte Antigens)IBA 12/2013 - 01/2002
4	Antiviral Agents (Antivirals)IBA 11/2011 - 12/2003
3	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2022 - 12/2016
3	VaccinesIBA 10/2020 - 08/2005
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2020 - 10/2017
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2019 - 07/2014
3	LigandsIBA 08/2015 - 06/2012
3	Rituximab (Mabthera)FDA Link 11/2014 - 01/2007
3	amotosalenIBA 05/2008 - 12/2003
2	Interleukin-12 (IL 12)IBA 01/2022 - 01/2012
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 12/2005
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2013
2	Abatacept (Orencia)FDA Link 10/2021 - 11/2013
2	IndolesIBA 01/2021 - 12/2018
2	Minor Histocompatibility AntigensIBA 01/2021 - 12/2009
2	indoleIBA 01/2021 - 12/2018
2	SteroidsIBA 01/2020 - 04/2009
2	Biological ProductsIBA 01/2020 - 01/2013
2	Alemtuzumab (Campath)FDA Link 01/2020 - 11/2015
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 07/2003
2	ibrutinibIBA 10/2019 - 11/2017

Therapy/Procedure

38	Therapeutics 01/2022 - 04/2003
29	Transplantation 10/2021 - 02/2002
22	Hematopoietic Stem Cell Transplantation 01/2022 - 07/2009
21	Cell Transplantation 11/2022 - 04/2010
19	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 01/2002
18	Stem Cell Transplantation 10/2021 - 06/2007
17	Drug Therapy (Chemotherapy) 10/2021 - 09/2002
11	Homologous Transplantation 01/2018 - 04/2004
10	Immunotherapy 01/2022 - 04/2004
6	Blood Component Removal (Apheresis) 01/2019 - 12/2004
6	Hematopoietic Stem Cell Mobilization 01/2017 - 10/2006
5	Autologous Transplantation 04/2015 - 10/2006
4	Photopheresis 02/2021 - 11/2010
3	Salvage Therapy 12/2020 - 10/2006
3	Radiotherapy 12/2020 - 06/2014
3	Haploidentical Transplantation 10/2019 - 06/2012
3	Erythrocyte Transfusion 01/2019 - 02/2015